Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Israel, H. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Respirators and Tuberculosis

right arrow Harold L. Israel, MD, MPH

1 January 1995 | Volume 122 Issue 1 | Pages 70-71


TO THE EDITOR:

The illuminating article by Nettleman and colleagues [1] places the cost of particulate respirator use in preventing tuberculosis in Veterans Administration hospital workers at $7 million per case prevented and $100 million per life saved. They assumed a case mortality rate of 7% on the basis of the national 1992 incidence and mortality rate figures. That mortality rate, however, is heavily concentrated in patients with the acquired immunodeficiency syndrome, homeless persons, alcoholic persons, and those born outside the United States. The case mortality rate among cooperative and well-nourished Veterans Administration health care workers should be less than 1%. If the case mortality rate among employees treated for tuberculosis is 1%, the cost per life saved by particulate respirators becomes $660 million. A more productive use of this vast sum can surely be devised by public health authorities.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReference

Thomas Jefferson University; Philadelphia, PA 19107


Reference
space
up arrowTop
up arrowAuthor & Article Info
dotReference

1. Nettleman MD, Fredrickson M, Good NL, Hunter SA. Tuberculosis control strategies: the cost of particulate respirators. Ann Intern Med. 1994; 121:37-40.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Israel, H. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online